Get started
Author

Maria-Elena Cabezudo

Predictive factors for a successful mobilization of peripheral blood CD34 + cells in multiple myeloma
2001 · Perea G., Sureda A., et al. · Annals of Hematology · 81
Lenalidomide and dexamethasone maintenance with or without ixazomib, tailored by residual disease status in myeloma
2023 · Laura Rosiñol, Albert Oriol, et al. · Blood · 65
PDF
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma
2022 · Rosalinda Termini, David Žihala, et al. · Clinical Cancer Research · 54
PDF
Postpartum ovarian vein thrombosis
2005 · Arancha Ugarriza, Rosa Espax, et al. · Thrombosis and Haemostasis · 52
Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders.
1999 · E Cabezudo, P Carrara, et al. · PubMed · 52
Analysis of residual disease in chronic lymphocytic leukemia by flow cytometry
1997 · E Cabezudo, E Matutes, et al. · Leukemia · 50
Patient Preferences for Multiple Myeloma Treatments: A Multinational Qualitative Study
2021 · Rosanne Janssens, Tamika Lang, et al. · Frontiers in Medicine · 44
PDF
Contribution of cerebrospinal fluid sCD19 levels to the detection of CNS lymphoma and its impact on disease outcome
2014 · Carmen Muñiz, Lourdes Martín-Martín, et al. · Blood · 33
Leukapheresis components may be cryopreserved at high cell concentrations without additional loss of HPC function
2000 · Elena Cabezudo, Clara Dalmases, et al. · Transfusion · 27
Ixazomib Plus Lenalidomide/Dexamethasone (IRd) Versus Lenalidomide /Dexamethasone (Rd) Maintenance after Autologous Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma: Results of the Spanish GEM2014MAIN Trial
2021 · Laura Rosinol, Albert Oriol, et al. · Blood · 25
Pomalidomide‐dexamethasone for treatment of soft‐tissue plasmacytomas in patients with relapsed / refractory multiple myeloma
2019 · Raquel Jiménez‐Segura, Miquel Granell, et al. · European Journal Of Haematology · 24
Single‐agent daratumumab in patients with relapsed and refractory multiple myeloma requiring dialysis: results of a Spanish retrospective, multicentre study
2019 · María J. Cejalvo, Mario Legarda, et al. · British Journal of Haematology · 22
PDF
Minimally Invasive Assessment of Peripheral Residual Disease During Maintenance or Observation in Transplant-Eligible Patients With Multiple Myeloma
2024 · Marta Lasa, Laura Notarfranchi, et al. · Journal of Clinical Oncology · 18
Assessment of Bone Health in Patients With Type 1 Gaucher Disease Using Impact Microindentation
2017 · Sabina Herrera, Jordi Pérez-López, et al. · Journal of Bone and Mineral Research · 15
PDF
Native valve endocarditis due to Candida parapsilosis: a late complication after bone marrow transplantation-related fungemia.
1994 · J A Cancelas, J Lopez, et al. · PubMed · 15
Cunninghamella Bertholletiae Infection (Mucormycosis) in a Patient with Acute T-cell Lymphoblastic Leukemia
2003 · X Ortín, L Escoda, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 13
Comparison of volumetric capillary cytometry with standard flow cytometry for routine enumeration of CD34+ cells
1999 · E. Cabezudo, S. Querol, et al. · Transfusion · 13
What matters most to patients with multiple myeloma? A Pan-European patient preference study
2022 · Rosanne Janssens, Tamika Lang, et al. · Frontiers in Oncology · 11
PDF
Real-World Evidence of Daratumumab Monotherapy in Relapsed/Refractory Multiple Myeloma Patients and Efficacy on Soft-Tissue Plasmacytomas
2022 · David F. Moreno, Victoria Clapés, et al. · Clinical Lymphoma Myeloma & Leukemia · 8
Biological and Clinical Significance of Undetectable Circulating Tumor Cells (CTCs) in Patients (Pts) with Multiple Myeloma (MM)
2023 · Juan-José Garcés, Rosalinda Termini, et al. · Blood · 6
Extranodal natural killer/T‐cell lymphoma nasal type in a western population: Molecular profiling identifies new therapeutic targets
2023 · Eva Gonzalez Barca, Laura Tomás‐Roca, et al. · American Journal of Hematology · 6
Mobilization kinetics of peripheral blood progenitor cells after IAPVP-16 salvage chemotherapy plus G-CSF in lymphoproliferative disorders
2000 · A Altés, R López, et al. · Bone Marrow Transplantation · 6
Real-world evidence of Carfilzomib, Lenalidomide and Dexamethasone (KRD) Scheme in patients with relapsed / refractory multiple myeloma
2025 · Antoni Garcia-Guiñon, Paola Andrea Charry, et al. · Annals of Hematology · 5
PDF
Current Approach in the Management of Secondary Immunodeficiency in Patients with Hematological Malignancies: Spanish Expert Consensus Recommendations
2023 · Concepción Boqué, Silvia Sánchez-Ramón, et al. · Journal of Clinical Medicine · 5
PDF
Candida parapsilopsis Fungemias in Bone Marrow Transplant Recipients: Implications for Azole Prophylactic Therapy
1997 · J. López-Jiménez, R. Duarte-Palomino, et al. · Blood · 5
Works count: 100
Citation count: 693
H-index: 15
I10-index: 18
Year
Topic
Type